Streptococcus salivarius K12 and Reduced Oral Mucositis Severity

Research synthesisLow evidenceModerate effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial moderate-sized effects of Streptococcus salivarius K12 on reducing oral mucositis severity, while 1 showed a neutral effect. The strongest evidence comes from a single randomized controlled trial (RCT) in 160 patients with head and neck tumors undergoing radiotherapy, where the probiotic significantly reduced the incidence of severe oral mucositis (36.6% vs 54.2%, p=0.035). Effects appear moderate in magnitude, but the evidence base is limited and findings are mixed.

Effective dose range: thrice daily (lozenges)
Studied populations: Patients with malignant head and neck tumors undergoing radiotherapy

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One clinical trial found no significant benefit for SsK12 compared to a different probiotic strain (SsM18), suggesting specific strain selection may matter. The neutral study had a smaller sample size and may have been underpowered.

Generated Jun 23, 2026

Safety in these studies

Overall tolerabilityReported
Topical clonidine, melatonin, oral pentoxifylline, topical SAMITAL or rhIL-11, oral SsK12, and curcumin may also be utilized but would benefit from validation in larger trials.
from: Managing strategies of chemotherapy and radiotherapy-induced oral mucositis.

3 of 3 papers

Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.
- 2024-04-20
- RCT · n = 160
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42(12)
- - Xingchen Peng
  - Zixia Li
  - Yiyan Pei
  - Shuhao Zheng
  - Jinchi Liu
  - Jingjing Wang
  - Ruidan Li
  - Xin Xu
- PubMed: 38215354
- DOI: 10.1200/jco.23.00837
2 Insights on
- Reduced Oral Mucositis Severity
- High evidence
- Large Human Trial
The incidence of SOM was significantly lower in the SsK12 group as compared with the placebo group (36.6% v 54.2%; P = .0351). The duration ... and time to develop SOM ... were also improved in the case of the SsK12 group.
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
thrice daily (lozenges)
Effectiveness of Streptococcus salivarius probiotics on alleviating radiation-induced oral mucositis via inflammatory and microecological modulation: a prospective pragmatic interventional study in nasopharyngeal carcinoma.
- 2026-03-03
- Clinical Trial
- Frontiers in immunology 17
- - Xiao-Tong Huang
  - Hui Feng
  - Ye Tan
  - Quan Wang
  - Jie-Mei Wei
  - Zhao-Dong Huang
  - Xin-Tong Wang
  - Hai-Jun Lu
- PubMed: 41853273
- DOI: 10.3389/fimmu.2026.1745549
4 Insights on
- Reduced Oral Mucositis Severity
- Moderate evidence
Compared with non-probiotic group, SsM18 significantly delayed OM onset (p = 0.014), reduced SOM duration (p = 0.019), and shortened total OM duration (p = 0.031), outperforming SsK12.
Effect
Neutral
Effect size
Small
Significant
No
Managing strategies of chemotherapy and radiotherapy-induced oral mucositis.
- 2025-02
- Review
- Cancer treatment reviews 133
- - Yuqi Wu
  - Wenjin Shi
  - Chunyu Li
  - Xiangfei Liu
  - Yuchen Jiang
  - Yan Qiu
  - Qianming Chen
  - Xiaobo Luo
- PubMed: 39799794
- DOI: 10.1016/j.ctrv.2025.102883
1 Insight on
- Reduced Oral Mucositis Severity
- Low evidence
probiotics like Streptococcus salivarius K12 and curcumin have shown effectiveness in randomized clinical trials
Effect
Beneficial
Effect size
Moderate
Significant
Yes

Streptococcus salivarius K12 and Reduced Oral Mucositis Severity

Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.

Effectiveness of Streptococcus salivarius probiotics on alleviating radiation-induced oral mucositis via inflammatory and microecological modulation: a prospective pragmatic interventional study in nasopharyngeal carcinoma.

Managing strategies of chemotherapy and radiotherapy-induced oral mucositis.